We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Submicroscopic Malaria Prevalence Reported in Immigrants

By LabMedica International staff writers
Posted on 30 Jul 2019
Print article
Image: Thin blood smear showing a Plasmodium falciparum gametocyte (single arrow) and a schizont of P. vivax (double arrow) from a mixed infection case (Photo courtesy of Sulekha Bhat et al).
Image: Thin blood smear showing a Plasmodium falciparum gametocyte (single arrow) and a schizont of P. vivax (double arrow) from a mixed infection case (Photo courtesy of Sulekha Bhat et al).
Malaria remains the most important parasitic infection for humans, causing about 2,000 deaths per day, especially in African children younger than five years old. The importance of submicroscopic malaria infections in high-transmission areas could contribute to maintain the parasite cycle.

Regarding non-endemic areas, its importance remains barely understood because parasitaemia in these afebrile patients is usually below the detection limits for microscopy, hence molecular techniques are often needed for its diagnosis. The prevalence of submicroscopic malaria among immigrants is unknown, and it is not clear if systematic screening or systematic treatment of immigrants from endemic areas would be necessary.

Scientists collaborating with the Hospital Universitario 12 de Octubre (Madrid, Spain) conducted a prospective, observational, multicenter study of 224 afebrile immigrants. Microscopic observation of Giemsa-stained thin and thick blood smears, and two different molecular techniques detecting Plasmodium spp. were performed. The commercial real-time polymerase chain reaction detecting Plasmodium spp. was performed. When this PCR was positive, a differential real-time PCR detecting Plasmodium malariae, P. falciparum, P. vivax and P. ovale was performed (FTD Malaria Differentiation, Fast-Track Diagnostics). In addition to this, blood samples were sent to the National Centre of Microbiology where a multiplex nested PCR detecting the four Plasmodium species was performed to validate the commercial PCR.

The scientists reported that 14 patients were defined as submicroscopic malaria cases by PCR, yielding a prevalence of 5.7% (95% confidence interval 3.45–9.40). In 230 patients (94.3%) all microbiological tests for malaria were negative. In 71.4% of the positive PCR/negative microscopy cases, Plasmodium falciparum alone was the main detected species (10 out of the 14 patients) and in four cases (28.6%) Plasmodium vivax or Plasmodium ovale were detected. One patient had a mixed infection including three different species.

The authors concluded that the prevalence of submicroscopic imported malaria found in this study was similar to that previously described by other authors in non-endemic areas in afebrile immigrants, namely P. vivax and P. ovale were involved in an important percentage of these infections. Screening protocols for afebrile immigrants with molecular techniques could be useful not only for a proper management and treatment of submicroscopic infections but also to prevent the potential reintroduction of malaria in areas where the vector is present. The study was published on July 17, 2019, in the Malaria Journal.

Related Links:
Hospital Universitario 12 de Octubre

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.